Cymbalta Nears Approval for Use on Chronic Pain - NYTimes.com
Links shared publicly online about this topic.
- 933total visits
Cymbalta Nears Approval for Use on Chronic Pain - NYTimes.com
View full resource at nytimes.com
Tags: Pain, Chronic Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, Cymbalta, Eli Lilly and Company
Most Recently Shared on August 20, 2010 at 11:02 pm By:
Eli Lilly closer to getting Cymbalta approved to help with chronic pain. FDA in favor with 8-6 vote. http://dld.bz/s9Ex
FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain
healthnews.com — “On Friday the U S Food and Drug Administration FDA approved Cymbalta duloxetine hydrochloride for use as a treatment for chronic musculoskeletal pain” View full resource at healthnews.com
Most Recently Shared on November 7, 2010 at 3:04 pm By:
FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain http://ht.ly/35IDB
FDA Approves Cymbalta for Chronic Musculoskeletal Pain
webmd.com — “A drug used to treat depression, anxiety, fibromyalgia, and diabetic neuropathy has been approved by the FDA for a new use -- to treat chronic musculoskeletal pain, including pain caused by osteoarthritis and chronic low back pain.” View full resource at webmd.com
Most Recently Shared on November 5, 2010 at 2:17 pm By:
FDA Approves Cymbalta for Chronic Musculoskeletal Pain http://bit.ly/9pH0fw
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis.The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:30 am By:
Brad Lipson, DO Family Medicine Doctor, Physician, Active Health Library, and Doctor
Eli Lilly's Cymbalta gets FDA nod for pain: NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulator... http://tinyurl.com/27cxlnk
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis. The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:00 am By:
Eli Lilly's Cymbalta gets FDA nod for pain http://dlvr.it/82yDg
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
spine-health.com — “Read what conditions the FDA advisory panel recommends for Cymbalta to treat.” View full resource at spine-health.com
Most Recently Shared on August 26, 2010 at 12:57 am By:
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain http://bit.ly/cuD8sU
UPDATE 2-FDA panel backs wider use of Eli Lilly's Cymbalta | Reuters
reuters.com — “* Eli Lilly's Cymbalta OK'd for chronic pain -FDA panel * Panelists split over back pain, arthritis use * Drugmaker seeking FDA approval to promote new use * FDA deadline passed, decision could come” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 3:59 pm By:
Women In Pain Health Organization
FDA panel supports Cymbalta for back pain, but not osteoarthritis http://www.reuters.com/article/idUSN1925181020100819 http://fb.me/FZGJbQkQ
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications - QualityPoint Technologies
qualitypointtech.net — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for Cymbalta (duloxetine HCl). The Committee's decision is not final - the FDA has to decide - however, the FDA usually goes along with what the Committee recommends. The Advisory Committee recommended the expanded use of Cymbalta for the treatment of chronic knee and lower back pain...” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 1:18 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications: The Anesthetic and Lif... http://bit.ly/cEcF29
Cymbalta Nears Approval for Use on Chronic Pain - QualityPoint Technologies
qualitypointtech.net — “An advisory panel to the Food and Drug Administration voted 8-6 to expand approved uses of Cymbalta. (Source: NYT Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 4:48 am By:
Cymbalta Nears Approval for Use on Chronic Pain: An advisory panel to the Food and Drug Administration voted 8-6 t... http://bit.ly/dahFVr
FDA Panel Supports Cymbalta for Chronic Pain
webmd.com — “An FDA advisory panel gave a closely divided vote of support to drugmaker Eli Lilly's application to increase the number of approved uses for one of its best-selling drugs, the antidepressant Cymbalta.” View full resource at webmd.com
Most Recently Shared on August 20, 2010 at 12:19 am By:
webMD: FDA Panel Supports Cymbalta for Chronic Pain http://bit.ly/9bfyNN Full http://bit.ly/cwUeLw
F.D.A. Panel Approves Use of Antidepressant for Pain - QualityPoint Technologies
qualitypointtech.net — “An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments. (Source: NYT Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 9:30 pm By:
F.D.A. Panel Approves Use of Antidepressant for Pain: An advisory committee votes to allow Eli Lilly to market Cym... http://bit.ly/bMBGWP
FDA questions wider approval of Lilly's Cymbalta | wfaa.com | Dallas - Fort Worth Business, National Business News
wfaa.com — “WASHINGTON (AP) --" Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain.” View full resource at wfaa.com
Most Recently Shared on August 18, 2010 at 11:25 pm By:
Women In Pain Health Organization
FDA questions wider approval of Lilly's Cymbalta http://www.wfaa.com/news/business/100882449.html# http://fb.me/uuXImEBk
Cymbalta Seeks Approval to Treat Chronic Pain, FDA Questions Safety - AOL Health
aolhealth.com — “Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain” View full resource at aolhealth.com
Most Recently Shared on August 18, 2010 at 8:30 pm By:
Could an antidepressant treat chronic pain? http://bit.ly/96p7BW
FDA Questions Wider Approval Of Cymbalta - QualityPoint Technologies
qualitypointtech.net — “Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain. (Source: WDSU.com - Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 18, 2010 at 8:06 am By:
FDA Questions Wider Approval Of Cymbalta: Federal health scientists are questioning whether the antidepressant Cym... http://bit.ly/9wJZ1Z
FDA questions wider approval of Lilly's Cymbalta
physorg.com — “(AP) -- Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain.” View full resource at physorg.com
Most Recently Shared on August 17, 2010 at 7:20 pm By:
PhysOrg Health News Health News
FDA questions wider approval of Lilly's Cymbalta http://tw.physorg.com/201274843
Lilly's Cymbalta helps chronic pain in U.S. review | Indianapolis Business Journal | IBJ.com
ibj.com — “Eli Lilly and Co.’s antidepressant Cymbalta helped people with chronic pain and wasn’t linked to new side effects, according to U.S. regulators weighing whether to expand use of the drugmaker’s second-biggest product. Cymbalta doses of 60 milligrams to 120 milligrams reduced pain more than placebos in studies of people with osteoarthritis of the knee or lower back pain, Food and Drug Administration staff said in a report released Tuesday. Outside advisers to the agency were ask” View full resource at ibj.com
Most Recently Shared on August 17, 2010 at 4:57 pm By:
Lilly's Cymbalta helps chronic pain in U.S. review: Approval for the millions of Americans with chronic back or kn... http://bit.ly/aOEVFb
Advertisement
